2,039
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Application of biological variation and six sigma models to evaluate analytical quality of six HbA1c analyzers and design quality control strategy

, , , &
Pages 3598-3602 | Received 28 May 2019, Accepted 04 Jul 2019, Published online: 28 Aug 2019

References

  • American Diabetes Association. Executive summary: standards of medical care in diabetes–2014. Diabetes Care. 2014;37:S5–S13.
  • Sandberg S, Fraser CG, Horvath AR, et al. Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med. 2015;53:833–835.
  • Njoroge SW, Nichols JH. Risk management in the clinical laboratory. Ann Lab Med. 2014;34:274–278.
  • Zhang C, Zhao H, Wang J, et al. The application of Six Sigma Techniques in the evaluation of enzyme measurement procedures in China. Clin Lab. 2015;61:461–465.
  • Mason SE, Nicolay CR, Darzi A. The use of Lean and Six Sigma methodologies in surgery: a systematic review. Surgeon. 2015;13:91–100.
  • Weykamp C, John G, Gillery P, et al. Investigation of 2 models to set and evaluate quality targets for hb a1c: biological variation and sigma-metrics. Clin Chem. 2015;61:752–759.
  • Westgard JO, Westgard SA. The quality of laboratory testing today: an assessment of sigma metrics for analytic quality using performance data from proficiency testing surveys and the CLIA criteria for acceptable performance. Am J Clin Pathol. 2006;125:343–354.
  • Westgard JO. Charts of operational process specifications (“OPSpecs charts”) for assessing the precision, accuracy, and quality control needed to satisfy proficiency testing performance criteria. Clin Chem. 1992;38:1226–1233; Discussion 1245–1250.
  • Qiu HW, Ruan LM, Zhao YG. Normalized MEDx chart coupled with Quality Goal Index for evaluation of analytical quality achievements and quality shortcomings. A novel perspective to its further application. Clin Chim Acta. 2015;444:278–279.
  • Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281.
  • Weykamp C, Siebelder C. Evaluation of performance of laboratories and manufacturers within the framework of the IFCC model for quality targets of HbA1c. J Diabetes Sci Technol. 2018;12:747–752.
  • Bruns DE, Boyd JC. Few point-of-care hemoglobin A1c assay methods meet clinical needs. Clin Chem. 2010;56:4–6.